|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
Medica Group PLC is a United Kingdom-based company, which provides teleradiology services. The Company provides outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerized tomography), ultrasound and plain film (x-ray) images. The Company, through its subsidiary, RadMD also provides pharmaceutical and biotech clients and contract research organizations (CROs) with complex imaging services for international clinical trials. It operates through three geographic segments: UK, Ireland, and the US. The UK segment includes two primary services to hospital radiology departments: NightHawk that provides reporting services; and Elective. The Elective offers cross-sectional reporting on MRI and CT scans, and plain film reporting on X-radiation (x -ray) images. The Ireland segment provides tele-radiology, managed services and a contract with the National Screening Service to deliver Ophthalmology services. The US segment provides radiology reporting.
- Sixth Floor, One Priory Square, HASTINGS, TN34 1EA
- Grant Thornton UK LLP
Latest News for MGP
Upcoming Events for MGP
Full Year 2022 Medica Group PLC Earnings Release
As of Today at 18:15 UTC, shares in Medica are trading at 150.00p. This share price information is delayed by 15 minutes.
Shares in Medica last closed at 150.00p and the price had moved by -9.09% over the past 365 days. In terms of relative price strength the Medica share price has underperformed the FTSE All Share Index by -10.84% over the past year.
The overall consensus recommendation for Medica is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Medica dividend yield is 1.81% based on the trailing twelve month period.
Last year, Medica paid a total dividend of £0.03, and it currently has a trailing dividend yield of 1.81%. We do not have any data on when Medica is to next pay dividends.
We do not have data on when Medica is to next pay dividends. The historic dividend yield on Medica shares is currently 1.81%.
To buy shares in Medica you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 150.00p, shares in Medica had a market capitalisation of £183.65m.
Here are the trading details for Medica:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MGP
Based on an overall assessment of its quality, value and momentum Medica is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Medica is 192.60p. That is 28.4% above the last closing price of 150.00p.
Analysts covering Medica currently have a consensus Earnings Per Share (EPS) forecast of £0.09 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medica. Over the past six months, its share price has underperformed the FTSE All Share Index by -1.49%.
As of the last closing price of 150.00p, shares in Medica were trading +0.57% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medica PE ratio based on its reported earnings over the past 12 months is 14.29. The shares last closed at 150.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medica's management team is headed by:
- Gordon Davis - NEC
- Stuart Quin - CEO
- Richard Jones - CFO
- Robert Lavis - OTH
- Junaid Bajwa - NID
- Joanne Easton - NID
- Barbara Moorhouse - NID